Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement

References

• Chobanian AV, Bakris GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. U.S. Department of Health and Human Services, National Institute of Health. Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf [Last accessed 3 March 2009]
   Google Scholar
• Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007;115:2761-88
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension – European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
   PubMed Web of Science ®Google Scholar
• Gu Q, Paulose-Ram R, Dillon C, et al. Antihypertensive medication use among US adults with hypertension. Circulation 2006;113:213-21
   PubMed Web of Science ®Google Scholar
• Hajjar I, Kotchen TA. Trends in the prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003;290:199-206
   PubMed Web of Science ®Google Scholar
• Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults, 1999–2004. Hypertension 2007;49:69-75
   PubMed Web of Science ®Google Scholar
• Law MR, Wald NJ, Morris JK, et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427-31
   PubMed Web of Science ®Google Scholar
• Neutel JM. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Curr Med Res Opin 2008;24:2389-401
   PubMed Web of Science ®Google Scholar
• Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 2000;9(Suppl.):2-6
   Google Scholar
• Jackson KC 2nd, Sheng X, Nelson RE, et al. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther 2008;30:1558-63
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-19
   PubMed Web of Science ®Google Scholar
• Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
   PubMed Web of Science ®Google Scholar
• Yang W, Chang J, Kahler KH, et al.Compliance and healthcare utilization among patients with hypertension treated with single pill vs. free combination antihypertensive therapy: U.S. national and state level results from a claims database analysis. Accepted as poster presentation at the ISPOR 15th Annual International Meeting, Atlanta GA, May 15–19, 2010
   Google Scholar
• Sapienza S, Sacco P, Floyd K, et al. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther 2003;25:1872-87
   PubMed Web of Science ®Google Scholar
• Shaya FT, Du D, Gbarayor CM, et al. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc 2009;101:34-9
   PubMed Web of Science ®Google Scholar
• Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003;9:324-32
   PubMedGoogle Scholar
• Brixner DI, Jackson KC 2nd, Sheng X, et al. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008;24:2597-607
   PubMed Web of Science ®Google Scholar
• Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239-45
   PubMed Web of Science ®Google Scholar
• Ebbutt AF, Elsdon-Dew RW. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K. J Int Med Res 1979;7:524-7
   PubMed Web of Science ®Google Scholar
• Forrest WA. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension. J Int Med Res 1980;8:127-31
   PubMed Web of Science ®Google Scholar
• Nissinen A, Tuomilehto J. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone. Pharmatherapeutica 1980;2:462-8
   PubMedGoogle Scholar
• Asplund J, Danielson M, Ohman P. Patients compliance in hypertension – the importance of number of tablets. Br J Clin Pharmacol 1984;17:547-52
   PubMed Web of Science ®Google Scholar
• Graham RD. Treating mild-to-moderate hypertension: a comparison of lisinopril–hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination. J Hum Hypertens 1991;5(Suppl. 2):59-60
   PubMedGoogle Scholar
• Mancia G, Omboni S; CARDIO (CAndesaRtan combined with DIuretic in hypertensiOn) Study Group. Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. Blood Press Suppl 2004;2:11-17
   PubMedGoogle Scholar
• Schweizer J, Hilsmann U, Neumann G, et al. Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination. Curr Med Res Opin 2007;23:2877-85
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Center for Health Statistics. Compressed Mortality File 1999–2005. CDC WONDER Online database. Available at: http://wonder.cdc.gov/cmf-icd10.html [Last accessed 4 August 2008]
   Google Scholar